Literature DB >> 9470079

Pulmonary complications in toxic epidermal necrolysis: a prospective clinical study.

F Lebargy1, P Wolkenstein, M Gisselbrecht, F Lange, J Fleury-Feith, C Delclaux, E Roupie, J Revuz, J C Roujeau.   

Abstract

OBJECTIVE: To evaluate the incidence, clinical features, and prognosis of pulmonary complications associated with toxic epidermal necrolysis
DESIGN: Prospective study.
SETTING: Dermatology intensive care unit in Mondor Hospital, France. PATIENTS: 41 consecutive patients.
INTERVENTIONS: On admission, then daily, respiratory evaluation was based on clinical examination, chest X-ray, and arterial blood gas analysis. When clinical symptoms, X-ray abnormalities, or hypoxemia [partial pressure of oxygen (PO2) < 80 mm Hg] were present, fiberoptic bronchoscopy was performed.
RESULTS: 10 patients presented early manifestations: dyspnea (n = 10), bronchial hypersecretion (n = 7), marked hypoxemia (n = 10) (PO2 = 59 +/- 8 mm Hg). Chest X-ray was normal (n = 8) or showed interstitial infiltrates (n = 2). In these 10 patients, fiberoptic bronchoscopy demonstrated sloughing of bronchial epithelium in proximal airways. Delayed pulmonary complications occurred in 6 of these 10 patients from day 7 to day 15: pulmonary edema (n = 2), atelectasis (n = 1), bacterial pneumonitis (n = 4). Mechanical ventilation was required in 9 patients. A fatal outcome occurred in 7 patients. Seven patients did not develop early pulmonary manifestations (PO2 on admission 87 +/- 6 mm Hg) but only delayed pulmonary symptoms related to atelectasis (n = 1), pulmonary edema (n = 4), and bacterial pneumonitis (n = 3); bronchial epithelial detachment was not observed. None of them required mechanical ventilation and all recovered with appropriate therapy.
CONCLUSIONS: "Specific" involvement of bronchial epithelium was noted in 27% of cases and must be suspected when dyspnea, bronchial hypersecretion, normal chest X-ray, and marked hypoxemia are present during the early stages of toxic epidermal necrosis. Bronchial injury seems to indicate a poor prognosis, as mechanical ventilation was required for most of these patients and was associated with a high mortality.

Entities:  

Mesh:

Year:  1997        PMID: 9470079      PMCID: PMC7095164          DOI: 10.1007/s001340050492

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  29 in total

1.  Laryngeal involvement in toxic epidermal necrolysis.

Authors:  D Wahle; D J Beste; S F Conley
Journal:  Otolaryngol Head Neck Surg       Date:  1992-12       Impact factor: 3.497

2.  Toxic epidermal necrolysis after bone marrow transplantation: study of nine cases.

Authors:  G Villada; J C Roujeau; C Cordonnier; M Bagot; M Kuentz; J Wechsler; J P Vernant
Journal:  J Am Acad Dermatol       Date:  1990-11       Impact factor: 11.527

Review 3.  Toxic epidermal necrolysis (Lyell syndrome).

Authors:  J C Roujeau; O Chosidow; P Saiag; J C Guillaume
Journal:  J Am Acad Dermatol       Date:  1990-12       Impact factor: 11.527

4.  Intestinal involvement in drug-induced toxic epidermal necrolysis.

Authors:  O Chosidow; J C Delchier; M T Chaumette; J Wechsler; P Wolkenstein; I Bourgault; J C Roujeau; J Revuz
Journal:  Lancet       Date:  1991-04-13       Impact factor: 79.321

5.  Toxic epidermal necrolysis. Clinical findings and prognosis factors in 87 patients.

Authors:  J Revuz; D Penso; J C Roujeau; J C Guillaume; C R Payne; J Wechsler; R Touraine
Journal:  Arch Dermatol       Date:  1987-09

6.  Toxic epidermal necrolysis associated with Mycoplasma pneumoniae infection.

Authors:  S Fournier; S Bastuji-Garin; H Mentec; J Revuz; J C Roujeau
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-06       Impact factor: 3.267

7.  Bronchial obstruction due to respiratory mucosal sloughing in toxic epidermal necrolysis.

Authors:  A Dasgupta; J O'Malley; R Mallya; J G Williams
Journal:  Thorax       Date:  1994-09       Impact factor: 9.139

8.  Multiple pulmonary complications in a patient with Stevens-Johnson syndrome.

Authors:  F S Virant; G J Redding; A H Novack
Journal:  Clin Pediatr (Phila)       Date:  1984-07       Impact factor: 1.168

9.  Involvement of macrophages in the pathology of toxic epidermal necrolysis.

Authors:  J C Roujeau; L Dubertret; S Moritz; H Jouault; M Heslan; J Revuz; R Touraine
Journal:  Br J Dermatol       Date:  1985-10       Impact factor: 9.302

10.  The culprit drugs in 87 cases of toxic epidermal necrolysis (Lyell's syndrome).

Authors:  J C Guillaume; J C Roujeau; J Revuz; D Penso; R Touraine
Journal:  Arch Dermatol       Date:  1987-09
View more
  25 in total

Review 1.  Toxic Epidermal Necrolysis and Steven-Johnson Syndrome: A Comprehensive Review.

Authors:  Olivia A Charlton; Victoria Harris; Kevin Phan; Erin Mewton; Chris Jackson; Alan Cooper
Journal:  Adv Wound Care (New Rochelle)       Date:  2020-01-09       Impact factor: 4.730

Review 2.  Severe cutaneous adverse reactions: emergency approach to non-burn epidermolytic syndromes.

Authors:  Manuel Florian Struck; Peter Hilbert; Maja Mockenhaupt; Beate Reichelt; Michael Steen
Journal:  Intensive Care Med       Date:  2009-09-29       Impact factor: 17.440

3.  Phenytoin-induced Lyell's syndrome.

Authors:  Bárbara Lobão; Claúdio Martins; Manuel Sousa; Susana Marques; Ermelinda Pedroso
Journal:  BMJ Case Rep       Date:  2012-12-10

4.  New insights in toxic epidermal necrolysis (Lyell's syndrome): clinical considerations, pathobiology and targeted treatments revisited.

Authors:  Philippe Paquet; Gérald E Piérard
Journal:  Drug Saf       Date:  2010-03-01       Impact factor: 5.606

Review 5.  Allergic emergencies encountered by the dermatologist. Severe cutaneous adverse drug reactions.

Authors:  P Wolkenstein; J Revuz
Journal:  Clin Rev Allergy Immunol       Date:  1999       Impact factor: 10.817

Review 6.  Toxic epidermal necrolysis and Stevens-Johnson syndrome.

Authors:  Thomas Harr; Lars E French
Journal:  Orphanet J Rare Dis       Date:  2010-12-16       Impact factor: 4.123

7.  Toxic epidermal necrolysis, DRESS, AGEP: do overlap cases exist?

Authors:  Sophie Bouvresse; Laurence Valeyrie-Allanore; Nicolas Ortonne; Marie Pauline Konstantinou; Sylvia H Kardaun; Martine Bagot; Pierre Wolkenstein; Jean-Claude Roujeau
Journal:  Orphanet J Rare Dis       Date:  2012-09-25       Impact factor: 4.123

8.  A six-month prospective study to find out the treatment outcome, prognosis and offending drugs in toxic epidermal necrolysis from an urban institution in kolkata.

Authors:  Sudip Das; Aloke Kumar Roy; Indranil Biswas
Journal:  Indian J Dermatol       Date:  2013-05       Impact factor: 1.494

Review 9.  Adverse cutaneous drug eruptions: current understanding.

Authors:  W Hoetzenecker; M Nägeli; E T Mehra; A N Jensen; I Saulite; P Schmid-Grendelmeier; E Guenova; A Cozzio; L E French
Journal:  Semin Immunopathol       Date:  2015-11-09       Impact factor: 11.759

Review 10.  Allopurinol hypersensitivity: a systematic review of all published cases, 1950-2012.

Authors:  Sheena N Ramasamy; Cameron S Korb-Wells; Diluk R W Kannangara; Myles W H Smith; Nan Wang; Darren M Roberts; Garry G Graham; Kenneth M Williams; Richard O Day
Journal:  Drug Saf       Date:  2013-10       Impact factor: 5.228

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.